Skip to content

Clinical trials

Scleroderma, Diffuse trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: Canada Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20102
20131
20141
20161
20172
20183
20194
20201
20212
20222
20234
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting4
Terminated4
Active, not recruiting3
Withdrawn2
Unknown status1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lady Davis Institute9
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's5
Bristol-Myers Squibb2
United Therapeutics2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Allogene Therapeutics1
AstraZeneca1
CSL Behring1
Corbus Pharmaceuticals Inc.1
Dinesh Khanna, MD, MS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse34
Scleroderma, Systemic22
Lung Diseases, Interstitial5
Connective Tissue Diseases3
Skin Diseases3
Arthritis, Rheumatoid2
Autoimmune Diseases2
Lupus Erythematosus, Systemic2
Raynaud Disease2
Alveolitis, Extrinsic Allergic1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.